Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.040
-0.020 (-0.65%)
Nov 21, 2024, 4:00 PM EST - Market closed
Xeris Biopharma Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 453 | 325 | 181 | 365 | - | - | |
| Market Cap Growth | 65.36% | 79.47% | -50.50% | - | - | - | |
| Enterprise Value | 658 | 487 | 226 | 360 | - | - | |
| Last Close Price | 3.06 | 2.35 | 1.33 | 2.93 | - | - | |
| PS Ratio | 2.35 | 1.98 | 1.64 | 7.37 | - | - | |
| PB Ratio | -14.99 | -47.86 | 4.00 | 3.84 | - | - | |
| EV/Sales Ratio | 3.51 | 2.97 | 2.05 | 7.26 | - | - | |
| Debt / Equity Ratio | -9.57 | -33.79 | 4.38 | 0.92 | 2.58 | 4.04 | |
| Asset Turnover | 0.58 | 0.49 | 0.34 | 0.21 | 0.15 | 0.02 | |
| Inventory Turnover | 0.84 | 0.90 | 1.06 | 1.01 | 1.77 | - | |
| Quick Ratio | 1.21 | 1.17 | 2.08 | 1.52 | 4.99 | 2.94 | |
| Current Ratio | 1.79 | 1.64 | 2.54 | 1.80 | 5.40 | 3.20 | |
| Return on Equity (ROE) | - | -324.20% | -134.83% | -190.28% | -378.20% | -279.56% | |
| Return on Assets (ROA) | -8.70% | -8.25% | -15.50% | -28.45% | -38.01% | -66.80% | |
| Return on Capital (ROIC) | -11.90% | -11.81% | -23.58% | -43.37% | -52.67% | -84.97% | |
| Earnings Yield | -13.79% | -19.18% | -52.34% | -33.59% | - | - | |
| FCF Yield | -7.05% | -15.18% | -57.18% | -26.44% | - | - | |
| Buyback Yield / Dilution | -5.01% | -1.51% | -71.62% | -85.32% | -63.32% | -116.75% | |
| Total Shareholder Return | -5.01% | -1.51% | -71.62% | -85.32% | -63.32% | -116.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.